3DBiofibr

PlantForm and 3DBioFibR announce NGen funding to advance recombinant human collagen fiber manufacturing technology Project leverages partners’ strengths to develop world’s first scalable dry spinning of recombinant human collagen for use in a broad range of sectors including regenerative medicine

3D BioFibR secures $3.52 million in seed funding for automated collagen fibre manufacturing 3D BioFibR, which offers an automated system for collagen fibre manufacturing, has raised $3.5 million in seed funding and contributions from government agencies.

3DBioFibR is a Research and Development Manager! If you have a strong background in life sciences and leading R&D projects, come join our team!

3D BioFibR Inc. hiring Research And Development Manager in Halifax, Nova Scotia, Canada | LinkedIn Posted 4:21:16 PM. 3D BioFibR Inc. is an advanced materials company that specializes in the manufacturing of protein…See this and similar jobs on LinkedIn.

“If everyone is moving forward together, then success takes care of itself” ― Henry Ford

Our new year’s resolution is to become the leading biofiber manufacturers in the world, and we are starting the year off right!

The lab at has been busy, as the team continues to make incredible breakthroughs in producing our and fibers.

Our proprietary dry spinning manufacturing process allows us to produce protein fibers at a and never seen before.

Checkout the video below for a sneak peek into our lab.

3D BioFibR Manufacturing Technique This video overviews 3D BioFibR's manufacturing technique.

We're on a mission to revolutionize tissue engineering and advanced material applications. Come join us!

3D BioFibR crew takes on HaliMac Axe Throwing - Halifax! 🪓🎯

Our team is excited to use this funding to continue scaling- up our manufacturing capabilities of our and fibers.

3D BioFibR Inc. Raises New Capital to Scale Up Manufacturing in an Oversubscribed Round 3D BioFibR Inc., a biofibre manufacturing company, announced today it has raised over $700,000 in an oversubscribed follow-on round. Proceeds from the